WTC Program Rejects Rare Kidney Coverage for Heroes
Published Date: 3/19/2026
Notice
Summary
The WTC Health Program reviewed a request to add Anti-GBM Glomerulonephritis, a kidney disease, to its list of covered health conditions but found not enough proof to do so. This means people affected by this disease won’t get new benefits or coverage changes right now. The decision was made official on March 19, 2026, with no immediate money or timing changes.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
WTC Program Denies Anti-GBM Coverage
The WTC Health Program denied Petition 026 to add Anti-Glomerular Basement Membrane (Anti-GBM) glomerulonephritis to the List of WTC-Related Health Conditions on March 19, 2026. The Science Team found Category V (inadequate evidence) because it identified no peer‑reviewed, published epidemiologic studies of Anti-GBM among 9/11‑exposed populations. As a result, people with this disease will not receive new WTC Health Program benefits or coverage changes at this time, and there are no immediate money or timing changes.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in